SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Voyager Therapeutics to Present VY1706 Study Design at CTAD 2026

The presentation concerns the design of Voyager's VY1706 Alzheimer's gene therapy study; no study results are reported.

VYGR

Related stories